Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr Harshil Dhutia, Registrar in Cardiology, St George’s university of LondonDr Michael Papadakis, Lecturer in cardiology, St George’s university of LondonProf Sanjay Sharma, Professor of clinical cardiology, St George’s university of London
A 16-year-old Caucasian international level cyclist underwent pre-participation cardiac screening. He reported no sinister cardiac symptoms or family history of heart disease or sudden cardiac death at a young age. Physical Examination was unremarkable.His 12 lead ECG is presented below.
Interested in learning more? Access the ESC e-learning platform and discover the EACPR Sports Cardiology online courses. Not yet an EACPR member?
for further reading:[*1] Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Corrado D, Pelliccia A, Heidbuchel H, Eur Heart J. 2010;31:243-259[*2] Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. Arruda MS, McClelland JH, Wang X, Beckman KJ, Widman LE, Gonzalez MD, Nakagawa H, Lazzara R, Jackman WM. J Cardiovasc Electrophysiol. 1998;9:2-12.[*3] Evaluation and management of Wolff-Parkinson-White in athletes. Rao AL, Salerno JC, Asif IM, Drezner J. Sports Health. 2014;6:326-32.[*4] Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Pelliccia A, Fagard R, Bjørnstad HH, et al.Eur Heart J. 2005;26:1422-45[*5] 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. Maron BJ, Zipes DP. J Am Coll Cardiol 2005;45:2–64.[*6] PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Cohen MI, Triedman JK,Cannon BC et al. Heart Rhythm. 2012;9:1006–1024
© 2017 European Society of Cardiology. All rights reserved